Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel antipsoriatic agents from AstraZeneca block the CXCR2 receptor

May 25, 2001

Imiquimod under investigation for various dermatological conditions

May 25, 2001

Dual antiinflammatory and antiproliferative effects reported for sPLA2 inhibitor

May 24, 2001

Topical R-115866 exerts retinoid activity without irritating skin

May 23, 2001

Development of psoriatic lesions in SCID mouse model inhibited by SB-239063

May 23, 2001

Vertex ICE inhibitor may have promise in inflammatory and autoimmune skin diseases

May 22, 2001

NicOx nitric oxide-releasing steroid shows no blanching effect in phase I

May 15, 2001

Proteasome inhibitor PS-519 holds promise as a therapy for psoriasis

May 14, 2001

Second azelaic acid-based acne product cleared for launch by FDA

May 14, 2001

Data presented for CX-659S this week at Japanese meeting support potential in dermatitis

May 11, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...